97432979

Information

  • Trademark
  • 97432979
  • Serial Number
    97432979
  • Filing Date
    May 27, 2022
    2 years ago
  • Transaction Date
    May 15, 2023
    a year ago
  • Status Date
    May 15, 2023
    a year ago
  • Location Date
    May 15, 2023
    a year ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Docket Number
    81844.0006
    Attorney Name
    Cynthia A. Moyer
    Law Office Assigned Location Code
    M40
  • Owners
Mark Drawing Code
2000
Case File Statements
  • GS0411: Providing entertainment information in the field of cannabis culture via a website; providing news via a website in the nature of current event reporting in the field of cannabis and cannabis culture; providing educational information in the field of cannabis via a website
  • DM0000: The mark consists of a sideways stylized "V" shape with three sun rays radiating out from the center of the "V.".
  • GS0051: Cannabis related products, namely, oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis and marijuana for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing the breeding, growing, cultivation, and harvesting of marijuana and cannabis; production of marijuana and cannabis, namely, cultivation of marijuana and cannabis plants
  • GS0311: Live cannabis plants; live marijuana plants; Cannabis seeds for agricultural purposes
  • GS0421: Research services in the area of marijuana and cannabis, cannabis related products, derivatives of cannabis, and natural health products containing cannabis
Case File Event Statements
  • 5/15/2023 - a year ago
    12 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/15/2023 - a year ago
    11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/15/2023 - a year ago
    10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 10/31/2022 - 2 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/31/2022 - 2 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/31/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/24/2022 - 2 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/1/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/1/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/4/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/3/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/31/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP